Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Neurocrine Biosciences (NBIX)
Technical Analysis Report for NASDAQ stock NBIX Neurocrine Biosciences. Dated: 13 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences then click here. or read Experts views on Neurocrine Biosciences or Forecast & share price targets of Neurocrine Biosciences
Neurocrine Biosciences Opened at 174.50 and Closed at: 174.10, which is -1.77% of previous session's close. It moved within a range of 172.03 and 175.88
The session was a Bearish session with an average volume of 1573200, which is 68.27% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 171.14 and resistance for tomorrow is 174.99
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 172.13, 170.15 resistance for tomorrow's hourly charts is 175.98, 177.85
10 Day SMA for Neurocrine Biosciences (NBIX) is 174.21 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Neurocrine Biosciences (NBIX) is 167.85 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Neurocrine Biosciences (NBIX) is 160.16 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 145.16 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Neurocrine Biosciences is 143.36 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Neurocrine Biosciences is at 167.85 and 200 DMA is at 143.36, while 50 DMA and 100 DMA are at 160.16 and 145.16 respectively
Neurocrine Biosciences (NBIX) moving average of 20 SMA is at 167.85 and 20 EMA is at 169.81
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Jul | 174.10 | 167.85 | 169.81 |
| 10 Fri Jul | 177.19 | 167.28 | 169.36 |
| 09 Thu Jul | 180.59 | 166.46 | 168.54 |
| 08 Wed Jul | 178.06 | 165.69 | 167.27 |
| 07 Tue Jul | 177.49 | 164.94 | 166.14 |
| 06 Mon Jul | 174.10 | 164.26 | 164.95 |
Neurocrine Biosciences (NBIX) moving average of 50 SMA is at 160.16 and 50 EMA is at 160.46
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Jul | 174.10 | 160.16 | 160.46 |
| 10 Fri Jul | 177.19 | 159.31 | 159.9 |
| 09 Thu Jul | 180.59 | 158.39 | 159.19 |
| 08 Wed Jul | 178.06 | 157.34 | 158.32 |
| 07 Tue Jul | 177.49 | 156.34 | 157.51 |
| 06 Mon Jul | 174.10 | 155.34 | 156.69 |
Neurocrine Biosciences (NBIX) moving average of 100 SMA is at 145.16 and 100 EMA is at 151.93
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Jul | 174.10 | 145.16 | 151.93 |
| 10 Fri Jul | 177.19 | 144.7 | 151.48 |
| 09 Thu Jul | 180.59 | 144.17 | 150.96 |
| 08 Wed Jul | 178.06 | 143.61 | 150.36 |
| 07 Tue Jul | 177.49 | 143.06 | 149.8 |
| 06 Mon Jul | 174.10 | 142.66 | 149.24 |
Neurocrine Biosciences (NBIX) moving average of 200 SMA is at 143.36 and 200 EMA is at 144.47
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Jul | 174.10 | 143.36 | 144.47 |
| 10 Fri Jul | 177.19 | 143.23 | 144.17 |
| 09 Thu Jul | 180.59 | 143.07 | 143.84 |
| 08 Wed Jul | 178.06 | 142.9 | 143.47 |
| 07 Tue Jul | 177.49 | 142.74 | 143.12 |
| 06 Mon Jul | 174.10 | 142.58 | 142.77 |
Neurocrine Biosciences has performed better than United Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Staar Surgical in short term. Holding Neurocrine Biosciences could be a better choice for now!
Scholar Rock has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Scholar Rock, about 14.83% more returns!
Rocket Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 26.29% more returns!
Neurocrine Biosciences has performed better than Moleculin Biotech in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Liquidia Technologies in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Lipocine Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Akari Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Atara Biotherapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Cogentix Medical in short term. Holding Neurocrine Biosciences could be a better choice for now!
Celldex Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 14.24% more returns!
Neurocrine Biosciences has performed better than Collplant Holdings in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Catalyst Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Denali Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Denali Therapeutics, about 13.27% more returns!
Editas Medicine has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Editas Medicine, about 17.42% more returns!
Neurocrine Biosciences has performed better than Evolus Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Fennec Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 10.46% more returns!
Icon Plc has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Icon Plc, about 4.65% more returns!
Inc Research has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Inc Research, about 0.22% more returns!
Neurocrine Biosciences Technical analysis of indicators
Price action analysis of Neurocrine Biosciences (NBIX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Neurocrine Biosciences in short term and the buy signal is strong.
Neurocrine Biosciences Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 173.66 and Neurocrine Biosciences NBIX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Neurocrine Biosciences NBIX stock. Volume based technical analysis of Neurocrine Biosciences NBIX stock is negative.
Neurocrine Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NBIX Experts View which covers a lot of information including buying and selling signals
NBIX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Neurocrine Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


